Linical (2183) Q2 2025 earnings summary

Executive summary

• Net sales for the six months ended September 30, 2024, declined 10.5% year-over-year to 5,426 million yen, with significant growth in the US offset by declines in other regions.

• Operating profit dropped to 192 million yen, down from 421 million yen in the prior year period, as only the US posted profit growth.

• Profit attributable to owners of parent was 280 million yen, up 61.8% year-over-year.

• Comprehensive income declined 27.6% year-over-year to 512 million yen.

• The company continues to expand globally, opening new offices in New Jersey and Australia, and focusing on M&A-driven growth.

Financial highlights

• Net sales: 5,426 million yen (down 10.5% year-over-year).

• Operating profit: 192 million yen (down 54.4% year-over-year).

• Ordinary profit: 239 million yen (down 50.5% year-over-year).

• Net profit: 280 million yen (up 61.8% year-over-year, likely due to non-operating items).

• Gross profit dropped to 1,314 million yen from 1,984 million yen year-over-year.

Outlook and guidance

• Full-year net sales forecast revised to 11,468 million yen, a 6.8% increase year-over-year.

• Operating profit forecast is 250 million yen, up 65.6% year-over-year.

• Net profit forecast reduced to 150 million yen, down 55.7% year-over-year.

• Net income per share forecast is 6.64 yen for the full year.

• Dividend forecast is 16 yen per share for the year ending March 31, 2025.